Glenmark Pharma’s generic drug to treat psoriatic arthritis gets U.S. FDA approval
Drug-maker Glenmark Pharmaceuticals’ Apremilast Tablets, 10 mg, 20 mg and 30 mg, a generic version of Amgen’s Otezla Tablets, 10 mg, 20 mg and 30 mg, has received final approval from the United States Food and Drug Administration (U.S. FDA). Otezla Tablets brand and therapeutic equivalents achieved annual sales of around $3.7 billion, Glenmark said…
Read More “Glenmark Pharma’s generic drug to treat psoriatic arthritis gets U.S. FDA approval ” »